Cite

HARVARD Citation

    Shen, J. et al. (2018). ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade. Nature medicine. pp. 556-562. [Online]. 
  
Back to record